These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 8823330)

  • 1. Use of hematopoietic colony-stimulating factors: the American Society of Clinical Oncology survey. The Health Services Research Committee of the American Society of Clinical Oncology.
    Bennett CL; Smith TJ; Weeks JC; Bredt AB; Feinglass J; Fetting JH; Hillner BE; Somerfield MR; Winn RJ
    J Clin Oncol; 1996 Sep; 14(9):2511-20. PubMed ID: 8823330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of hematopoietic colony-stimulating factors: comparison of the 1994 and 1997 American Society of Clinical Oncology surveys regarding ASCO clinical practice guidelines. Health Services Research Committee of the American Society of Clinical Oncology.
    Bennett CL; Weeks JA; Somerfield MR; Feinglass J; Smith TJ
    J Clin Oncol; 1999 Nov; 17(11):3676-81. PubMed ID: 10550166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth factor usage patterns and outcomes in the community setting: collection through a practice-based computerized clinical information system.
    Swanson G; Bergstrom K; Stump E; Miyahara T; Herfindal ET
    J Clin Oncol; 2000 Apr; 18(8):1764-70. PubMed ID: 10764438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: results from the 1997 American Society of Clinical Oncology survey. Health Services Research Committee of the American Society of Clinical Oncology.
    Bennett CL; Bishop MR; Tallman MS; Somerfield MR; Feinglass J; Smith TJ
    Ann Oncol; 1999 Nov; 10(11):1355-9. PubMed ID: 10631465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.
    Liang DC
    Paediatr Drugs; 2003; 5(10):673-84. PubMed ID: 14510625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines.
    J Clin Oncol; 1994 Nov; 12(11):2471-508. PubMed ID: 7964965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.
    Rusthoven J; Bramwell V; Stephenson B
    Cancer Prev Control; 1998 Aug; 2(4):179-90. PubMed ID: 10093631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colony-stimulating factors for the management of neutropenia in cancer patients.
    Dale DC
    Drugs; 2002; 62 Suppl 1():1-15. PubMed ID: 12479591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of granulocyte colony-stimulating factor (G-CSF) in clinical practice in Fukuoka City area in Japan.
    Tamura K
    Fukuoka Igaku Zasshi; 1999 Jun; 90(6):279-85. PubMed ID: 10423924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of granulocyte colony-stimulating factor: a survey among Italian medical oncologists.
    Danova M; Rosti G; De Placido S; Bencardino K; Venturini M
    Oncol Rep; 2005 Dec; 14(6):1405-12. PubMed ID: 16273232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy.
    Herbst C; Naumann F; Kruse EB; Monsef I; Bohlius J; Schulz H; Engert A
    Cochrane Database Syst Rev; 2009 Jan; (1):CD007107. PubMed ID: 19160320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte colony-stimulating factor use in cancer patients.
    Baker J; McCune JS; Harvey RD; Bonsignore C; Lindley CM
    Ann Pharmacother; 2000; 34(7-8):851-7. PubMed ID: 10928394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
    J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.
    Bohlius J; Reiser M; Schwarzer G; Engert A
    Cochrane Database Syst Rev; 2004; (3):CD003189. PubMed ID: 15266474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of colony-stimulating factor use in US academic health centers.
    Yim JM; Matuszewski KA; Vermeulen LC; Ratko TA; Burnett DA; Vlasses PH
    Ann Pharmacother; 1995 May; 29(5):475-81. PubMed ID: 7544655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factor practice patterns among pediatric oncologists: results of a 1998 Pediatric Oncology Group Survey. Economic Evaluation Working Group the Pediatric Oncology Group.
    Parsons SK; Mayer DK; Alexander SW; Xu R; Land V; Laver J
    J Pediatr Hematol Oncol; 2000; 22(3):227-41. PubMed ID: 10864054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.
    Bohlius J; Reiser M; Schwarzer G; Engert A
    Cochrane Database Syst Rev; 2004; (1):CD003189. PubMed ID: 14974009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.
    Bohlius J; Herbst C; Reiser M; Schwarzer G; Engert A
    Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD003189. PubMed ID: 18843642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulopoiesis-stimulating factors in the prevention for adverse effects in the therapeutic treatment of malignant lymphoma.
    Bohlius J; Reiser M; Schwarzer G; Engert A
    Cochrane Database Syst Rev; 2002; (4):CD003189. PubMed ID: 12519588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.